ACRP CCRA EXAM 2026-2027 - ULTIMATE TEST
BANK EXAM WITH 200 Comprehensive Questions
with Detailed Answers & Clinical Rationales
Association of Clinical Research Professionals
Certified Clinical Research Associate Exam
This comprehensive test bank contains 200 meticulously crafted questions
covering every domain of the ACRP Certified Clinical Research Associate
(CCRA) Examination. Each question is designed to challenge your knowledge
and prepare you for the complexity of the actual exam. Detailed rationales
explain not only why the correct answer is right, but also why the distractors
are wrong, reinforcing essential clinical research knowledge.
Key Features:
- ✅ 200 Authentic Exam-Style Questions
- ✅ Detailed Clinical Rationales for Every Answer
- ✅ Based on Current ACRP CCRA Blueprint and ICH GCP Guidelines
- ✅ Covers All 8 Domains of the CCRA Exam
- ✅ Complex yet Understandable Questions
- ✅ Complete Answer Key for Quick Reference
- ✅ Updated for 2026-2027 Examination Cycle
,DOMAIN 1: REGULATORY AND ETHICAL FRAMEWORKS (Questions 1-40)
Question 1
Which of the following statements is TRUE regarding FDA guidance for
industry investigator responsibilities?
A) FDA guidance documents establish legally enforceable responsibilities
B) FDA guidance documents describe the agency's current thinking and should
be viewed only as recommendations
C) FDA guidance documents are legally binding contracts
D) FDA guidance documents supersede federal regulations
Correct Answer: B
Rationale: FDA guidance documents do not establish legally enforceable
responsibilities. Instead, guidance documents describe the agency's current
thinking on a topic and should be viewed only as recommendations, unless
specific regulatory or statutory requirements are cited. This distinction is
critical for clinical research professionals to understand, as guidance
documents provide valuable direction but are not legally binding like
regulations. The FDA uses guidance to communicate its expectations and
recommendations to industry and investigators.
,Question 2
What are the expectations regarding the qualifications of an investigator?
A) Be qualified by education, training, and experience to assume responsibility
for trial conduct
B) Be thoroughly familiar with appropriate use of investigational product
C) Permit for monitoring, auditing, and inspection
D) All of the above
Correct Answer: D
Rationale: Investigators must meet all three qualifications: (1) be qualified by
education, training, and experience to assume responsibility for proper trial
conduct; (2) be thoroughly familiar with the appropriate use of the
investigational product; and (3) permit monitoring and auditing by the
sponsor and inspection by regulatory authorities. These requirements ensure
that investigators are competent to conduct clinical trials and protect subject
safety.
Question 3
If an investigator is a non-physician, what provision must be made?
A) The investigator may refer subjects to any healthcare provider
B) The investigator should make adequate provision for necessary medical
care
C) The investigator must have a physician co-investigator
D) The investigator cannot conduct clinical trials
, Correct Answer: B
Rationale: If the investigator is a non-physician, the investigator should make
adequate provision for necessary medical care. This ensures that subjects
have access to appropriate medical care if needed during the trial. Non-
physician investigators can conduct trials but must have arrangements in
place for medical oversight.
Question 4
Which of the following is a true statement regarding protecting subject rights,
safety, and welfare?
A) Providing subjects with a method of communication for questions or
concerns
B) Adhering to the protocol to avoid exposing subjects to unreasonable risk
C) Providing reasonable access to needed medical care
D) All of the above
Correct Answer: D
Rationale: Protecting subject rights, safety, and welfare includes: (1) providing
subjects with a method of communication for questions or concerns; (2)
adhering to the protocol so subjects aren't exposed to unreasonable risk; and
(3) providing reasonable access to needed medical care. These are
fundamental investigator responsibilities that ensure subjects are protected
throughout the trial.
BANK EXAM WITH 200 Comprehensive Questions
with Detailed Answers & Clinical Rationales
Association of Clinical Research Professionals
Certified Clinical Research Associate Exam
This comprehensive test bank contains 200 meticulously crafted questions
covering every domain of the ACRP Certified Clinical Research Associate
(CCRA) Examination. Each question is designed to challenge your knowledge
and prepare you for the complexity of the actual exam. Detailed rationales
explain not only why the correct answer is right, but also why the distractors
are wrong, reinforcing essential clinical research knowledge.
Key Features:
- ✅ 200 Authentic Exam-Style Questions
- ✅ Detailed Clinical Rationales for Every Answer
- ✅ Based on Current ACRP CCRA Blueprint and ICH GCP Guidelines
- ✅ Covers All 8 Domains of the CCRA Exam
- ✅ Complex yet Understandable Questions
- ✅ Complete Answer Key for Quick Reference
- ✅ Updated for 2026-2027 Examination Cycle
,DOMAIN 1: REGULATORY AND ETHICAL FRAMEWORKS (Questions 1-40)
Question 1
Which of the following statements is TRUE regarding FDA guidance for
industry investigator responsibilities?
A) FDA guidance documents establish legally enforceable responsibilities
B) FDA guidance documents describe the agency's current thinking and should
be viewed only as recommendations
C) FDA guidance documents are legally binding contracts
D) FDA guidance documents supersede federal regulations
Correct Answer: B
Rationale: FDA guidance documents do not establish legally enforceable
responsibilities. Instead, guidance documents describe the agency's current
thinking on a topic and should be viewed only as recommendations, unless
specific regulatory or statutory requirements are cited. This distinction is
critical for clinical research professionals to understand, as guidance
documents provide valuable direction but are not legally binding like
regulations. The FDA uses guidance to communicate its expectations and
recommendations to industry and investigators.
,Question 2
What are the expectations regarding the qualifications of an investigator?
A) Be qualified by education, training, and experience to assume responsibility
for trial conduct
B) Be thoroughly familiar with appropriate use of investigational product
C) Permit for monitoring, auditing, and inspection
D) All of the above
Correct Answer: D
Rationale: Investigators must meet all three qualifications: (1) be qualified by
education, training, and experience to assume responsibility for proper trial
conduct; (2) be thoroughly familiar with the appropriate use of the
investigational product; and (3) permit monitoring and auditing by the
sponsor and inspection by regulatory authorities. These requirements ensure
that investigators are competent to conduct clinical trials and protect subject
safety.
Question 3
If an investigator is a non-physician, what provision must be made?
A) The investigator may refer subjects to any healthcare provider
B) The investigator should make adequate provision for necessary medical
care
C) The investigator must have a physician co-investigator
D) The investigator cannot conduct clinical trials
, Correct Answer: B
Rationale: If the investigator is a non-physician, the investigator should make
adequate provision for necessary medical care. This ensures that subjects
have access to appropriate medical care if needed during the trial. Non-
physician investigators can conduct trials but must have arrangements in
place for medical oversight.
Question 4
Which of the following is a true statement regarding protecting subject rights,
safety, and welfare?
A) Providing subjects with a method of communication for questions or
concerns
B) Adhering to the protocol to avoid exposing subjects to unreasonable risk
C) Providing reasonable access to needed medical care
D) All of the above
Correct Answer: D
Rationale: Protecting subject rights, safety, and welfare includes: (1) providing
subjects with a method of communication for questions or concerns; (2)
adhering to the protocol so subjects aren't exposed to unreasonable risk; and
(3) providing reasonable access to needed medical care. These are
fundamental investigator responsibilities that ensure subjects are protected
throughout the trial.
